Cargando…
Synthesis of [(2)H(5)]baricitinib via [(2)H(5)]ethanesulfonyl chloride
Baricitinib, typically applied as a treatment for rheumatoid arthritis, has recently attracted the attention of clinicians and researchers as a potential treatment for COVID‐19. Naturally, there has been a need for the preparation of the isotope‐labelled analogue of baricitinib to probe the pharmaco...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313827/ https://www.ncbi.nlm.nih.gov/pubmed/35277889 http://dx.doi.org/10.1002/jlcr.3969 |